GRI Bio (GRI) Competitors 1.04 -0.06 (-5.45%) (As of 09:06 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends GRI vs. VRAX, FBRX, VCNX, ADIL, AEZS, ONVO, PRTG, MBRX, ERNA, and CDIOShould you be buying GRI Bio stock or one of its competitors? The main competitors of GRI Bio include Virax Biolabs Group (VRAX), Forte Biosciences (FBRX), Vaccinex (VCNX), Adial Pharmaceuticals (ADIL), Aeterna Zentaris (AEZS), Organovo (ONVO), Portage Biotech (PRTG), Moleculin Biotech (MBRX), Eterna Therapeutics (ERNA), and Cardio Diagnostics (CDIO). These companies are all part of the "pharmaceutical products" industry. GRI Bio vs. Virax Biolabs Group Forte Biosciences Vaccinex Adial Pharmaceuticals Aeterna Zentaris Organovo Portage Biotech Moleculin Biotech Eterna Therapeutics Cardio Diagnostics Virax Biolabs Group (NASDAQ:VRAX) and GRI Bio (NASDAQ:GRI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends. Do institutionals and insiders believe in VRAX or GRI? 8.6% of Virax Biolabs Group shares are held by institutional investors. Comparatively, 34.0% of GRI Bio shares are held by institutional investors. 45.1% of Virax Biolabs Group shares are held by insiders. Comparatively, 0.3% of GRI Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer VRAX or GRI? GRI Bio received 1 more outperform votes than Virax Biolabs Group when rated by MarketBeat users. CompanyUnderperformOutperformVirax Biolabs GroupN/AN/AGRI BioOutperform Votes1100.00% Underperform VotesNo Votes Do analysts prefer VRAX or GRI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Virax Biolabs Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AGRI Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, VRAX or GRI? Virax Biolabs Group has higher revenue and earnings than GRI Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVirax Biolabs Group$156.42K42.16-$6.73MN/AN/AGRI BioN/AN/A-$13.04MN/AN/A Does the media prefer VRAX or GRI? In the previous week, Virax Biolabs Group's average media sentiment score of 0.00 equaled GRI Bio'saverage media sentiment score. Company Overall Sentiment Virax Biolabs Group Neutral GRI Bio Neutral Is VRAX or GRI more profitable? Virax Biolabs Group's return on equity of 0.00% beat GRI Bio's return on equity.Company Net Margins Return on Equity Return on Assets Virax Biolabs GroupN/A N/A N/A GRI Bio N/A -331.02%-174.48% Which has more risk and volatility, VRAX or GRI? Virax Biolabs Group has a beta of 1.93, indicating that its share price is 93% more volatile than the S&P 500. Comparatively, GRI Bio has a beta of -2.06, indicating that its share price is 306% less volatile than the S&P 500. SummaryVirax Biolabs Group beats GRI Bio on 6 of the 9 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRI vs. The Competition Export to ExcelMetricGRI BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.05M$6.74B$5.02B$8.40BDividend YieldN/A7.94%7.52%4.16%P/E RatioN/A11.84128.6416.67Price / SalesN/A269.811,718.2576.46Price / CashN/A46.0936.9133.53Price / Book0.205.304.595.18Net Income-$13.04M$150.82M$114.09M$223.67M7 Day Performance53.80%-1.09%110.28%2.59%1 Month Performance190.50%15.18%124.25%8.66%1 Year Performance-99.06%36.68%154.82%28.23% GRI Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRIGRI Bio0.0797 of 5 stars1.04-5.5%N/A-99.0%$3.05MN/A0.001Gap UpHigh Trading VolumeVRAXVirax Biolabs Group0.4083 of 5 stars$2.18-1.4%N/A-19.7%$7.04M$160,000.000.005Gap UpFBRXForte Biosciences1.5484 of 5 stars$4.58-0.9%$3.25-29.0%+21,670.8%$6.75MN/A-0.255Upcoming EarningsVCNXVaccinex1.373 of 5 stars$3.79+1.3%N/A-77.3%$6.55M$356,000.00-0.0640Upcoming EarningsHigh Trading VolumeADILAdial Pharmaceuticals0.7251 of 5 stars$1.02-1.9%N/A-55.3%$6.53MN/A0.0020Positive NewsAEZSAeterna Zentaris1.1817 of 5 stars$3.61-3.0%$60.00+1,562.9%-39.5%$6.47M$2.37M-0.2420News CoverageGap UpONVOOrganovo0.1843 of 5 stars$0.45+4.7%N/A-72.6%$6.40M$73,000.00-0.3220Analyst ForecastPRTGPortage Biotech1.6299 of 5 stars$5.95+2.6%$120.00+1,916.8%-85.8%$6.25MN/A-0.136Positive NewsMBRXMoleculin Biotech1.8857 of 5 stars$2.62flat$35.00+1,235.9%-68.0%$6.06MN/A0.0020Upcoming EarningsPositive NewsERNAEterna Therapeutics0.234 of 5 stars$1.10+7.8%N/A-20.6%$5.95M$70,000.00-0.2510Upcoming EarningsCDIOCardio Diagnostics3.0907 of 5 stars$0.26-16.2%$2.00+671.6%-30.6%$5.88M$39,138.000.007Upcoming EarningsGap DownHigh Trading Volume Related Companies and Tools Related Companies VRAX Alternatives FBRX Alternatives VCNX Alternatives ADIL Alternatives AEZS Alternatives ONVO Alternatives PRTG Alternatives MBRX Alternatives ERNA Alternatives CDIO Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GRI) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRI Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
